Frontiers | Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy
Frontiers | PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
Frontiers | The Role of PD-1 in Acute and Chronic Infection
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer | Nature Immunology
The diverse functions of the PD1 inhibitory pathway | Nature Reviews Immunology
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - ScienceDirect
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy - ScienceDirect
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations | Science Translational Medicine
Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer Immunotherapy | Journal of the American Chemical Society
PD-1 in T-cell activation, exhaustion, and effector function. (A) T... | Download Scientific Diagram
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer | Science Advances
Emerging biomarkers as predictors to anti-PD1/PD-L1 therapies in advanced melanoma. | Semantic Scholar
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports
PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity | Nature Communications
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
Frontiers | PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
Frontiers | The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance
Summary of biomarkers of the response to anti-PD-1/PD-L1 immunotherapy.... | Download Scientific Diagram
Learning from PD-1 Resistance: New Combination Strategies: Trends in Molecular Medicine
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy | PNAS
Raji-hPD-1 cells | ADCC targets | InvivoGen
PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer - ScienceDirect
Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells | Scientific Reports
PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicity | PLOS Pathogens
Immune checkpoint blockade in HIV - eBioMedicine
High IL-8 correlates with reduced response to PD-1/PD-L1 checkpoint blockade
